Latest filing published 02 Jun 2023 for Adicet Bio, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Bastiano Sanna span 2 companies, the busiest being Vertex Pharmaceuticals INC / MA and Adicet Bio, Inc. Over a trading history stretching from 30 April 2021 to 1 June 2023, the count stands at 31 filings.
Sales make up the whole of the open-market record (15 sales, €3.3M). Other entries cover 16 share grants. 2023 to date brings no purchases and 7 sales.
The newest entry dates from 2 June 2023: a share grant, in Adicet Bio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations